Observational study / 2014
High-dose vitamin B-12 supplement use was not linked to higher vitamin B-12 status in children, adolescents, or older adults compared with lower doses.
Using Canadian Health Measures Survey data (2007-2009) from ~5600 participants aged 6-79 y, researchers examined associations between daily supplemental vitamin B-12 dose and biomarkers of status. Supplement users had 33% higher serum vitamin B-12 and a 4.2% higher prevalence of adequacy than non-users. However, children and adolescents consuming >10 μg/d of supplemental vitamin B-12 did not exhibit higher serum vitamin B-12, higher adequacy prevalence, or lower tHcy than those consuming >0-10 μg/d. Serum vitamin B-12 plateaued at doses of >25 μg/d in adults aged 46-59 y and >10-25 μg/d in adults aged 60-79 y, with no dose-related differences in adequacy or tHcy in adults >45 y.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional survey
- Who was studied
- Nationally representative sample of ~5600 Canadians aged 6-79 years
- What was measured
- Serum vitamin B-12 and plasma total homocysteine (tHcy)
THE PAPER
High-dose compared with low-dose vitamin B-12 supplement use is not associated with higher vitamin B-12 status in children, adolescents, and older adults.
MacFarlane AJ, Shi Y, Greene-Finestone LS. J Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.